CoChat

Effects of cholecystokinin (CCK)-8, CCK-33, and gastric inhibitory polypeptide (GIP) on basal and meal-stimulated pancreatic hormone secretion in man

Ahrén, Bo, Pettersson, Magnus, Uvnäs-Moberg, Kerstin, Gutniak, Mark, Efendic, Suad · 1991 · Diabetes Research and Clinical Practice

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Abstract

Gastrointestinal hormones with insulinotropic effects, like cholecystokinin (CCK) and gastric inhibitory polypeptide (GIP) might tentatively be used in the treatment of non-insulin-dependent diabetes mellitus. We therefore examined the effects of intravenous injection of pharmacological dose levels of CCK-8 (100 and 300 pmol/kg), CCK-33 (100 pmol/kg), GIP (100 pmol/kg), and CCK-8 plus GIP (100 pmol/kg of each) on plasma levels of glucose, insulin, somatostatin, glucagon, and pancreatic polypeptide (PP) in healthy human volunteers. The peptides were given under basal conditions or in combination with a mixed meal. CCK-8, CCK-33, and GIP were all found to increase the basal plasma levels of insulin, somatostatin, and PP; the increases were observed already in samples taken at 2 min after the injection. In contrast, the plasma glucagon levels were unaffected by the peptides. CCK-8, CCK-33, and GIP (100 pmol/kg) all potentiated the meal-induced plasma responses of insulin and PP, whereas plasma levels of glucagon after the meal were not affected. Plasma somatostatin levels after the meal were increased by GIP but not affected by CCK-8 or CCK-33. CCK-8 and GIP together (100 pmol/kg for both) increased plasma levels of insulin, PP and somatostatin as much as each of the peptides given alone, both under basal conditions and after the meal intake. Plasma levels of glucagon were not affected by CCK-8 and GIP together. We conclude that in man, both CCK-8, CCK-33, and GIP moderately stimulate basal and meal related insulin release without any synergistic effects and that the peptides do not inhibit the secretion of glucagon.

Overview

Integrity signals

Registry

Crossref · 10.1016/0168-8227(91)90059-m

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 35 references

Research works printed but not linked: 1

  1. Hildebrand, 1990, Cholecystokinin (CCK) is not an incretin in humans, Digestion, 46, 143

Cited by

See all 50

Metadata

Authors
Ahrén, B., Pettersson, M., Uvnäs-Moberg, K., Gutniak, M., & Efendic, S.
Affiliations
  • Lund University (SE)
  • Karolinska University Hospital (SE)
Venue
Diabetes Research and Clinical Practice
Publisher
Elsevier BV
Published
1991-09
Volume
13
Issue
3
Pages
153-161
ISSN
0168-8227 (ISSN-L)
OpenAlex
W2167719373
Cited by
50
References
34
Citations by year
2026: 1 · 2025: 2 · 2021: 1 · 2020: 1 · 2019: 1 · 2018: 2 · 2016: 3 · 2015: 3 · 2014: 1 · 2013: 3 · 2012: 3
FWCI
2.53
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Diabetes Research and Clinical Practice (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
Keywords
cholecystokinin-8, glucose-dependent insulinotropic polypeptide, insulin secretion, pancreatic hormone secretion, somatostatin, glucagon, pancreatic polypeptide, type 2 diabetes, gastrointestinal hormones, synergistic effect
MeSH terms
Insulin Secretion, Adult, Blood Glucose, Cholecystokinin, Eating, Female, Gastric Inhibitory Polypeptide, Glucagon, Humans, Insulin, Kinetics, Male, Pancreatic Hormones, Pancreatic Polypeptide, Reference Values, Sincalide, Somatostatin, Time Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of cholecystokinin (CCK)-8, CCK-33, and gastric inhibitory polypeptide (GIP) on basal and meal-stimulated pancreatic hormone secretion in man. https://app.cochat.ai/papers/10.1016/0168-8227(91)90059-m
The paper
Ahrén, B., Pettersson, M., Uvnäs-Moberg, K., Gutniak, M., & Efendic, S. (1991). Effects of cholecystokinin (CCK)-8, CCK-33, and gastric inhibitory polypeptide (GIP) on basal and meal-stimulated pancreatic hormone secretion in man. Diabetes Research and Clinical Practice. https://doi.org/10.1016/0168-8227(91)90059-m

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.